AaeX is primarily used to study Yersinia pathogenesis and host immune responses.
Antibody Development: Recombinant AaeX serves as an antigen for generating serotype-specific antibodies, aiding in diagnostic assays .
ELISA: Quantitative detection of anti-AaeX antibodies in serum samples to assess immune responses .
Cellular Assays: While direct evidence for AaeX’s role is limited, its homology to effector proteins suggests potential involvement in:
AaeX is distinct from other Yersinia virulence factors but shares structural or functional parallels with:
Functional Elucidation: Current research lacks direct evidence of AaeX’s role in Yersinia pathogenesis. Further studies are needed to:
Identify host targets (e.g., integrins, Rho GTPases).
Assess its contribution to bacterial survival or immune evasion.
Diagnostic Potential: AaeX could be a biomarker for serotyping Y. pseudotuberculosis strains, though validation is required.
KEGG: ypb:YPTS_3734